Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.00 (0.00%)
Bid:
24.00
Ask:
26.00
Spread: 2.00 (8.333%)
Market Cap: £27.00m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Trading Update

8 Feb 2017 07:00

RNS Number : 2638W
Elektron Technology PLC
08 February 2017
 

Elektron Technology plc

(AIM: EKT, "Elektron" or the "Group")

 

Year-end trading update

 

Elektron Technology plc, the global technology group, is pleased to provide an update on trading covering its financial year ended 31 January 2017.

 

Group Trading

 

Group revenue from continuing operations of approximately £34.5m (unaudited) compared with £35.5m (on a like for like basis) for the previous year. Trading in the second half of the year on continuing operations showed some recovery from the slowdown in the first half. Revenue from continuing operations in the second half was £17.9m (unaudited) (2016: £17.7m) compared with £16.6m (unaudited) for the first half. Underlying trading performance from continuing operations benefitted from the improved mix of sales and further cost savings to offset the impact of the overall fall of £1m in sales when compared to the previous financial year.

 

As announced on 8 December 2016, the Group proposes to close its Torquay site in August of this year at a cost of approximately £0.8m, for which the Group has made a full provision at 31 January 2017.

 

During the year Bulgin successfully rolled out its 4000 series through its distribution channel and will launch its new "M-series" connector series during the first quarter, followed by a number of other new products during the course of the year.

 

Further investment in new products has been made in Queensgate to demonstrate the capability of its technology and widen its accessible market size (planned for release in late Spring of 2017).

 

Checkit launched two new products in the second half of the year being the next generation Checkit Automated Monitoring system and the Checkit Solo Work Management system for SMEs. The interest from the food sector remains strong with a number of pilots underway and a major facilities management company signing up at a number of sites. Checkit is now operational across a number of UK sites across a diverse customer base, ranging from food manufacturing plants to high end restaurants.

 

Elektron Eye Technology continues to grow its ophthalmic market share and will show a fifth consecutive year of organic sales growth, following investment and phased launch of its new product suite. Further product enhancements and functionality are planned in the current year.

 

Following a review of Sheen's product offering a number of products have been identified for enhancement and value engineering to drive sales and margin growth.

 

Net cash as at 31 January 2017 was £1.0m (unaudited) (31 January 2016: net debt £1.6m) benefitting from proceeds of £2.6m received from business disposals in the year. As planned, cash generated from operations fully funded the Group's investment programme. 

 

Outlook 

The Board continues to be cautious in its outlook due to macro-economic conditions and continued sales order visibility of 5-7 weeks.

 

In the current financial year the Group will continue to pursue its rationalisation programme and aims to conclude the sale of Digitron and Titman Tip Tools. Once these businesses have been disposed of, Elektron will be in a position to target a return to growth in sales across each of the remaining businesses. The Group plans to maintain its focus on new product development and will invest the excess of the cash generated from its operations in FY18 in order to grow and maintain the momentum in the established brands, fledgling growth brands and in completing the proposed site consolidation.

 

John Wilson, Chief Executive Officer of Elektron, said:

 

"The sale of low growth and non-core businesses has enabled the Group to not only return to a net cash position for the first time in many years but has enabled greater focus of management time on the areas of the business targeted for growth. Further simplification is planned for the current financial year creating a more focussed group with greater growth opportunities. We shall maintain investment in new product development."

 

For further information:

 

Elektron Technology www.elektron-technology.com

 

+44 (0)1223 371 000

John Wilson - Chief Executive Officer

Andy Weatherstone - Chief Financial Officer

 

 

finnCap (Nominated Adviser and Broker)

+44 (0)20 7220 0500

Ed Frisby/Scott Mathieson (Corporate Finance)

 

Malar Velaigam (Corporate Broking)

 

 

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

 

Notes to Editors

Elektron conceives, designs and markets innovative engineered products and services for businesses that connect, monitor and control

 

We have a multi skilled team of engineers, software and product line specialists based in Cambridge focused on the opportunities created by global trends in the following areas:

 

- Demand for ubiquitous power and data: Bulgin

- New waves of "aware" business applications: Checkit

- The effect of ageing on sight: Elektron Eye Technology

- Quality testing and inspection instruments: Sheen

- Growth in high precision manufacture: Queensgate

 

In addition, Elektron owns a portfolio of well-established products and brands that provide cash flow as well as customer access and feedback

 

Forward looking statements

Statements contained in this trading statement are based on the knowledge and information available to the Company's directors at the date it was prepared and therefore the facts stated and views expressed may change after that date. By their nature, the statements concerning the risks and uncertainties facing the Company in this Statement involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. To the extent that this Statement contains any statement dealing with any time after the date of its preparation such statement is merely predictive and speculative as it relates to events and circumstances which are yet to occur. The Company undertakes no obligation to update these forward looking statements.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSSSFIWFWSEFE
Date   Source Headline
26th Jan 20167:00 amRNSDirectorate Change
20th Jan 20163:22 pmRNSHolding(s) in Company
25th Nov 20157:00 amRNSProduct Launch
24th Nov 20153:21 pmRNSHolding(s) in Company
10th Nov 20157:00 amRNSTrading Update
19th Oct 20153:41 pmRNSDerivative Claim - Update
5th Oct 20157:00 amRNSProduct Launch
28th Sep 20157:00 amRNSDirector's Dealing
14th Sep 20154:12 pmRNSDirector's dealing
10th Sep 20157:00 amRNSDirectorate Changes
10th Sep 20157:00 amRNSHalf Yearly Report
30th Jul 20154:45 pmRNSResult of AGM
23rd Jul 20159:00 amRNSTrading Update
22nd Jul 20157:00 amRNSDerivative claim - update
16th Jul 20154:09 pmRNSDerivative Claim - Update
8th Jul 20153:16 pmRNSLapse of Options
6th Jul 20153:49 pmRNSNotice of AGM
26th Jun 20154:00 pmRNSHolding(s) in Company
18th Jun 20158:50 amRNSDerivative Claim - Update
12th Jun 20154:42 pmRNSAnnual Report and Financial Statements
30th Apr 20157:00 amRNSFinal Results
27th Apr 20155:35 pmRNSHolding(s) in Company
7th Apr 20151:41 pmRNSHolding(s) in Company
12th Feb 20157:00 amRNSYear end trading update
28th Jan 201512:45 pmRNSDerivative Claim - Further Update
24th Nov 20147:00 amRNSTrading update
2nd Oct 20147:00 amRNSDerivative Claim - Update
31st Jul 20146:06 pmRNSResult of AGM
31st Jul 20147:00 amRNSAGM Statement
25th Jul 201411:15 amRNSDirector/PDMR Shareholding
17th Jul 201412:15 pmRNSResult of Open Offer
9th Jul 20148:00 amRNSNotice of AGM
25th Jun 20145:42 pmRNSHolding(s) in Company
23rd Jun 20147:00 amRNSPlacing and Proposed Open Offer
23rd Jun 20147:00 amRNSUnaudited full year results
20th Jun 20147:00 amRNSConclusion of Strategic Alternatives Process
17th Jun 20147:00 amRNSStatement regarding Elektron Technology plc
2nd Jun 20145:33 pmRNSForm 8 (OPD) Microgen plc
2nd Jun 201412:35 pmRNSForm 8.3 - [Microgen Plc]
27th May 20142:10 pmRNSStatement re Elektron Technology Plc
21st May 20149:00 amRNSResponse to Microgen
20th May 201412:39 pmRNSFurther Statement Re Elektron Technology Plc
20th May 201410:20 amRNSStatement re Elektron Technology
13th May 20143:20 pmRNSStrategic Alternatives Process Update
29th Apr 201410:09 amRNSHolding(s) in Company - Replacement
25th Apr 20142:03 pmRNSForm 8.3 - Elektron Technology Plc
25th Apr 20141:45 pmRNSForm 8 (DD) - [Elektron Technology PLC]
23rd Apr 20145:32 pmRNSForm 8.3 - [Elektron Technology Plc]
23rd Apr 20143:22 pmRNSForm 8.3 - [Elektron Technology]
23rd Apr 20143:15 pmPRNForm 8.3 - Elektron Technology Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.